TrialMedicina (Kaunas, Lithuania)2024
Comparing the Risk of Infusion-Related Reactions and Tolerability in Patients Given Cetirizine or Diphenhydramine Prior to Ocrelizumab Infusion (PRECEPT).
Kyle Smoot et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
2024
this papercites it